Glenmark Generics gets US FDA nod for cirrhosis drug
Glenmark Generics has received final approval from US Food and Drugs Administration (FDA) for its abbreviated new drug application (ANDA) for Ursodiol tablets used in treatment of patients with primary biliary cirrhosis (PBC).
July 13, 2011 / 14:58 IST
Moneycontrol Bureau
Glenmark Generics has received final approval from US Food and Drugs Administration (FDA) for its abbreviated new drug application (ANDA) for Ursodiol tablets used in treatment of patients with primary biliary cirrhosis (PBC).PBC is a chronic liver disease that slowly destroys the ducts that drain bile in the liver. Glenmark
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
